Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1β, TNF-α and IL-6 in an in-vitro model of brain inflammation
<p>Abstract</p> <p>Background</p> <p>Brain inflammation plays a central role in multiple sclerosis (MS). Dimethylfumarate (DMF), the main ingredient of an oral formulation of fumaric acid esters with proven therapeutic efficacy in psoriasis, has recently been found to a...
Main Authors: | Mrowietz Ulrich, Rickert Uta, Rostami-Yazdi Martin, Sievers Jobst, Wilms Henrik, Lucius Ralph |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-05-01
|
Series: | Journal of Neuroinflammation |
Online Access: | http://www.jneuroinflammation.com/content/7/1/30 |
Similar Items
-
IL-1 and TNF mediates IL-6 signaling at the maternal-fetal interface during intrauterine inflammation
by: Pietro Presicce, et al.
Published: (2024-06-01) -
Novel Influences of IL-10 on CNS Inflammation Revealed by Integrated Analyses of Cytokine Networks and Microglial Morphology
by: Warren D. Anderson, et al.
Published: (2017-08-01) -
Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro
by: H Wilms, et al.
Published: (2003-12-01) -
Inhibition of NF-κB and AP-1 by dimethylfumarate correlates with down-regulated IL-6 secretion and proliferation in human lung fibroblasts
by: P Seidel, et al.
Published: (2010-12-01) -
The Suppression of Adjuvant-induced Inflammation and the Inhibition of the Serum and Tissue IL-17, TNF-α and IL-1β levels by Thymol and Carvacrol
by: Nasser Gholijani, et al.
Published: (2017-06-01)